Analyst Price Targets — RZLT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 8, 2026 1:04 pm | — | Wedbush | $2.00 | $2.22 | TheFly | Rezolute price target raised to $2 from $1 at Wedbush |
| December 12, 2025 2:19 pm | Jason McCarthy | Maxim Group | $4.00 | $1.58 | TheFly | Rezolute price target lowered to $4 from $20 at Maxim |
| December 12, 2025 11:05 am | Douglas Tsao | H.C. Wainwright | $5.00 | $1.40 | TheFly | Rezolute price target lowered to $5 from $14 at H.C. Wainwright |
| December 11, 2025 8:32 pm | Albert Lowe | Craig-Hallum | $2.00 | $1.40 | TheFly | Rezolute downgraded to Hold from Buy at Craig-Hallum |
| December 11, 2025 5:30 pm | Julian Harrison | BTIG | $5.00 | $1.40 | TheFly | Rezolute price target lowered to $5 from $17 at BTIG |
| December 11, 2025 3:45 pm | — | Wedbush | $1.00 | $1.25 | TheFly | Wedbush downgrades Rezolute to Neutral after congenital hyperinsulinism miss |
| December 5, 2025 8:28 pm | — | Jefferies | $20.00 | $10.42 | TheFly | Rezolute price target raised to $20 from $15 at Jefferies |
| October 29, 2025 9:42 am | — | JMP Securities | $17.00 | $9.49 | TheFly | Rezolute price target raised to $17 from $9 at Citizens JMP |
| September 18, 2025 4:23 pm | — | Maxim Group | $20.00 | $8.20 | TheFly | Rezolute price target raised to $20 from $15 at Maxim |
| September 20, 2024 5:22 am | Julian Harrison | BTIG | $7.50 | $2.41 | StreetInsider | BTIG Reiterates Buy Rating on Rezolute (RZLT) |
Latest News for RZLT
REDWOOD CITY, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by all forms of hyperinsulinism (HI), today announced that management will participate in the Citizens Life Sciences Conference, taking place March 10-11, 2026, in Miami, FL.
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Rezolute To Contact Him Directly To Discuss Their Options
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Rezolute To Contact Him Directly To Discuss Their Options If you suffered significant losses in Rezolute stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Rezolute To Contact Him Directly To Discuss Their Options
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Rezolute To Contact Him Directly To Discuss Their Options If you suffered significant losses in Rezolute stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for RZLT.
U.S. House Trading
No House trades found for RZLT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.